Yanase, Fumitaka
Spano, Sofia
Maeda, Akinori
Chaba, Anis
Naorungroj, Thummaporn
Ow, Connie Pei Chen
Lankadeva, Yugeesh R.
May, Clive N.
Betrie, Ashenafi H.
Lane, Darius J. R.
Eastwood, Glenn M.
Plummer, Mark P.
Bellomo, Rinaldo
Clinical trials referenced in this document:
Documents that mention this clinical trial
Mega-dose sodium ascorbate: a pilot, single-dose, physiological effect, double-blind, randomized, controlled trial
https://doi.org/10.1186/s13054-023-04644-x
Funding for this research was provided by:
Hospital Research Foundation Group Fellowship
Anaesthesia and Intensive Care Trust at Austin Health
Article History
Received: 26 July 2023
Accepted: 9 September 2023
First Online: 12 October 2023
Declarations
:
: Ethics approval was obtained from Austin Health Human Research Ethics Committee (HREC/64579/Austin-2020). Written informed consent for enrolment or consent to continue and use patient data was obtained from all patients or the legally responsible person.
: Written informed consent for publication was obtained from all patients or the legally responsible person.
: YRL, CNM and RB own a patent for the use of mega-dose sodium ascorbate in the treatment of sepsis.